These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1371274)

  • 1. The catalytic functions of chimeric reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
    Shaharabany M; Hizi A
    J Biol Chem; 1992 Feb; 267(6):3674-8. PubMed ID: 1371274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of chimeric human immunodeficiency virus types 1 and 2 reverse transcriptases for structure-function analysis and for mapping susceptibility to nonnucleoside inhibitors.
    Yang G; Song Q; Charles M; Drosopoulos WC; Arnold E; Prasad VR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(4):326-33. PubMed ID: 8601218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors.
    Shih CK; Rose JM; Hansen GL; Wu JC; Bacolla A; Griffin JA
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9878-82. PubMed ID: 1719542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic properties of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
    Hizi A; Tal R; Shaharabany M; Loya S
    J Biol Chem; 1991 Apr; 266(10):6230-9. PubMed ID: 1706712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is modulated by residue 294 of the small subunit.
    Sevilya Z; Loya S; Adir N; Hizi A
    Nucleic Acids Res; 2003 Mar; 31(5):1481-7. PubMed ID: 12595556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The catalytic properties of the reverse transcriptase of the lentivirus equine infectious anemia virus.
    Rubinek T; Loya S; Shaharabany M; Hughes SH; Clark PK; Hizi A
    Eur J Biochem; 1994 Feb; 219(3):977-83. PubMed ID: 7509281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of inhibition of endogenous human immunodeficiency virus type 1 reverse transcription by 2',3'-dideoxynucleoside 5'-triphosphate, tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepin-2(1H)-thion e, and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives.
    Debyser Z; Vandamme AM; Pauwels R; Baba M; Desmyter J; De Clercq E
    J Biol Chem; 1992 Jun; 267(17):11769-76. PubMed ID: 1376311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits.
    Sevilya Z; Loya S; Hughes SH; Hizi A
    J Mol Biol; 2001 Aug; 311(5):957-71. PubMed ID: 11531332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single conservative amino acid substitution in the reverse transcriptase of human immunodeficiency virus-1 confers resistance to (+)-(5S)-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)imidazo[4,5, 1- jk][1,4]benzodiazepin-2(1H)-thione (TIBO R82150).
    Mellors JW; Im GJ; Tramontano E; Winkler SR; Medina DJ; Dutschman GE; Bazmi HZ; Piras G; Gonzalez CJ; Cheng YC
    Mol Pharmacol; 1993 Jan; 43(1):11-6. PubMed ID: 7678690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of cysteine mutations on the reverse transcriptases of human immunodeficiency virus types 1 and 2.
    Hizi A; Shaharabany M; Tal R; Hughes SH
    J Biol Chem; 1992 Jan; 267(2):1293-7. PubMed ID: 1370463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of the DNA polymerase and ribonuclease H activities of human immunodeficiency virus type 2 reverse transcriptase expressed in Escherichia coli.
    Hizi A; Tal R; Hughes SH
    Virology; 1991 Jan; 180(1):339-46. PubMed ID: 1701948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of human immunodeficiency virus type 1 reverse transcriptase to TIBO derivatives induced by site-directed mutagenesis.
    de Vreese K; Debyser Z; Vandamme AM; Pauwels R; Desmyter J; de Clercq E; Anné J
    Virology; 1992 Jun; 188(2):900-4. PubMed ID: 1374986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DNA-dependent and RNA-dependent DNA polymerase activities of the reverse transcriptases of human immunodeficiency viruses types 1 and 2.
    Shaharabany M; Hizi A
    AIDS Res Hum Retroviruses; 1991 Nov; 7(11):883-8. PubMed ID: 1722105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors.
    Hizi A; Tal R; Shaharabany M; Currens MJ; Boyd MR; Hughes SH; McMahon JB
    Antimicrob Agents Chemother; 1993 May; 37(5):1037-42. PubMed ID: 7685994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of illimaquinone, a selective inhibitor of the RNase H activity, with the reverse transcriptases of human immunodeficiency and murine leukemia retroviruses.
    Loya S; Hizi A
    J Biol Chem; 1993 May; 268(13):9323-8. PubMed ID: 7683648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.
    Auwerx J; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2004 Jan; 65(1):244-51. PubMed ID: 14722257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of the chimeric reverse transcriptase of simian immunodeficiency virus sensitive to nonnucleoside reverse transcriptase inhibitor.
    Isaka Y; Sato A; Kawauchi S; Suyama A; Miki S; Hayami M; Fujiwara T
    Microbiol Immunol; 1998; 42(3):195-202. PubMed ID: 9570285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric inhibition of human immunodeficiency virus type 1 reverse transcriptase by tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione compounds.
    Debyser Z; Pauwels R; Andries K; Desmyter J; Engelborghs Y; Janssen PA; De Clercq E
    Mol Pharmacol; 1992 Jan; 41(1):203-8. PubMed ID: 1370707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors.
    Debyser Z; De Vreese K; Knops-Gerrits PP; Baekelandt V; Bhikhabhai R; Strandberg B; Pauwels R; Anné J; Desmyter J; De Clercq E
    Mol Pharmacol; 1993 Apr; 43(4):521-6. PubMed ID: 7682649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-clade inhibition of recombinant human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus SIVcpz reverse transcriptases by RNA pseudoknot aptamers.
    Held DM; Kissel JD; Thacker SJ; Michalowski D; Saran D; Ji J; Hardy RW; Rossi JJ; Burke DH
    J Virol; 2007 May; 81(10):5375-84. PubMed ID: 17329328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.